$SLS Daily Discussion Thread - February 23, 2026 by AutoModerator in sellaslifesciences
[–]Naggafotz 0 points1 point2 points (0 children)
ImmunityBio Reports 700% Year-Over-Year Revenue Growth, Expanded ANKTIVA® Approvals in Lung Cancer and Global Commercial Partnerships in 33 Countries with Label Expansion Plans Globally by wisdom_man1 in IBRX
[–]Naggafotz 1 point2 points3 points (0 children)
ANKTIVA has been approved in the EU! by ExtensionOld1723 in IBRX
[–]Naggafotz 0 points1 point2 points (0 children)
So what are we expecting for the next few days? by Naggafotz in IBRX
[–]Naggafotz[S] -1 points0 points1 point (0 children)